Welcome to the Brigham Health Department of Radiology Drug Trial Business Unit. We are pleased to offer contract research organizations, core-imaging labs, biopharmaceutical and biotechnology companies the full spectrum of imaging-related services in support of clinical trials and other studies.
With a team of more than 100 board-certified, sub-specialized radiologists and nearly 200 PhD's, the program provides access to the expertise and technology of a premiere academic radiology department.
What We Do
We are available to provide services to support clinical trials and other studies involving radiological imaging. Offering the expertise of world-renowned radiologists and PhDs to provide blinded reads and extensive consultative services for the benefit of your clinical trial. With over 20 years of clinical trial experience, our radiologists understand the unique needs of CROs and pharmaceutical companies, and are well equipped to handle even the most challenging of studies.
Our experienced radiologists have participated in a broad range of work, such as oncology trials, nuclear medicine imaging for metastatic disease, musculoskeletal imaging for arthritis, cardiovascular imaging for pulmonary vein and cardiac assessment, pelvic ultrasound for leiomyoma treatment and endometriosis, CT for renal calculi assessment, and MRI for liver, spleen, and kidney organ volumes in hematologic and congenital conditions.
Interested in learning more? Do you need expertise that is not listed here? Please contact us to discuss our expertise in further detail.
Interested in learning more about how we can partner with you on your clinical trial? Please contact our leadership team via email at DTBU_Admin@bwh.harvard.edu or call (617) 732-5358. We are looking forward to working with you.